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Summary
The p16INK4a/pRB/E2F and p19ARF/p53 tumor suppressor pathways are disrupted in most human cancers. Both p19ARF and
p53 are required for the induction of senescence in primary mouse embryonic fibroblasts (MEFs), but little is known about
their downstream targets. Disruption of E2F-mediated transcriptional repression in MEFs caused a general increase in the
expression of E2F target genes, including p19ARF. We detected no contribution of E2F-mediated transactivation in this
setting, indicating that a predominant role of endogenous E2F in asynchronously growing primary MEFs is to repress its
target genes. Moreover, relief of transcriptional repression by E2F rendered MEFs resistant to senescence induced by
either p19ARF, p53, or RASV12. Thus, E2F transcriptional repressor complexes are critical downstream targets of antiprolifera-
tive p19ARF/p53 signaling.
Introduction When a constitutively active mutant allele of the Ha-RAS
gene (encoding RASV12) is introduced into primary MEFs, they
also enter replicative senescence, but now prematurely (SerranoUpon explantation, cultured primary murine embryonic fibro-
blasts (MEFs) divide only a limited number of times before they et al., 1997). Both spontaneous and RASV12-induced senescence
depend on the presence of functional p19ARF and p53, asundergo replicative senescence (Hayflick, 1965; reviewed in
Sherr and DePinho, 2000). This cell cycle arrest is accompanied primary fibroblasts deficient for either of these genes can be
cultured indefinitely, irrespective of RASV12 expression (Kamijoby increased levels of the p16INK4a, p19ARF (both encoded by the
INK4a locus), p53, and p21CIP1 proteins. Both p16INK4a and p19ARF et al., 1997; Serrano et al., 1997; Tanaka et al., 1994). However,
how activation of the p19ARF/p53 pathway by (RASV12-induced)are induced during in vitro propagation of primary MEFs. p16INK4a
inhibits cellular proliferation in a manner that requires the func- senescence signaling eventually results in an irreversible cell
cycle arrest is not well understood. As MEFs deficient for p21CIP1tion of either the retinoblastoma protein pRB or, as shown re-
cently, both pRB-related “pocket” proteins, p107 and p130 are not immortal and still undergo RASV12- or p19ARF-induced
arrest, p21CIP1 likely is not a critical p19ARF/p53 target gene in(Bruce et al., 2000; Koh et al., 1995; Lukas et al., 1995; Medema
et al., 1995). p19ARF, too, is a tumor suppressor gene that has this setting (Groth et al., 2000; Pantoja and Serrano, 1999).
PML is required for the regulation of p53 (Ferbeyre et al., 2000;been proposed to protect cells against excessive mitogenic or
oncogenic signaling (Sherr, 1998). p19ARF neutralizes the E3- Pearson et al., 2000), but which target genes act downstream
of p53 in the senescence response remains unknown.ubiquitin ligase for p53, MDM-2, and thereby stabilizes p53
(Pomerantz et al., 1998; Zhang et al., 1998). As a result of When primary cells enter either RASV12-induced or spontane-
ous senescence, pRB accumulates in its active, hypophosphor-p19ARF expression, p53 transcriptionally induces its target genes,
including MDM-2 and the cell cycle inhibitor p21CIP1 (Vogelstein ylated form (Serrano et al., 1997; Stein et al., 1990). We and
others recently reported that both spontaneous and RASV12-et al., 2000; Vousden, 2000). Although p53 is a regulatory target
of p19ARF, the latter can interfere with cell cycle progression in induced senescence are dependent on the retinoblastoma gene
family. Fibroblasts deficient for all three pocket proteins (pRB,both p53-dependent and p53-independent manners (Carnero
et al., 2000; Martelli et al., 2001; Weber et al., 2000). p107, and p130) were shown to be immortal and failed to se-
S I G N I F I C A N C E
E2F transcriptional repressor complexes are considered to be important downstream components of the p16INK4a/pRB tumor suppressor
pathway. We find that E2F repressors are also critical targets for the ARF and p53 tumor suppressors during induction of replicative
senescence and cell cycle arrest. Hence, our finding suggests that p16INK4a and ARF/p53 converge at the level of E2F repressor
complexes. This is unexpected, because the pRB and p53 pathways were thought to communicate to different downstream targets.
As E2F repressors are controlled by these two major tumor suppressor pathways, our model predicts that E2F-dependent transcriptional
repression is deregulated not only by a mutant p16INK4a/pRB pathway, but also upon mutation of the ARF/p53 pathway, i.e., in the
vast majority of human tumors.
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nesce upon expression of either RASV12 or p19ARF (Dannenberg inhibition requires active E2F-mediated transcriptional repres-
sion (Zhang et al., 1999).et al., 2000; Peeper et al., 2001; Sage et al., 2000). pRB interacts
The mechanism of action of E2F-DB has previously beenwith a number of proteins involved in cell cycle regulation, in-
shown to involve binding to E2F sites and subsequent displace-cluding MDM-2 (Xiao et al., 1995), PML (Alcalay et al., 1998),
ment of endogenous E2Fs, as demonstrated by electrophoreticthe tyrosine kinase c-ABL (Welch and Wang, 1993), and E2F
mobility shift assays (EMSAs) in both fibroblasts and epithelialtranscription factors (Helin et al., 1992; Kaelin et al., 1992), but
cells (Krek et al., 1995; Zhang et al., 1999). First, we wished towhich of these act in the senescence response is unclear.
establish whether E2F-DB displaces endogenous E2F from E2FThe E2F transcription factor family consists of six structurally
sites also in MEFs. Indeed, upon infection of MEFs with E2F-related members, five of which (E2F-1 through E2F-5) contain
DB-encoding retroviruses, we observed that the DNA bindinga transactivation domain that is inhibited by binding to a pocket
activity of endogenous E2F was almost completely abolishedprotein. E2F-1, -2, and -3 preferentially associate with pRB,
and replaced by an E2F-DB/DNA complex (Figure 1B). ThisE2F-4 with p107 or p130, and E2F-5 with p130 (Muller and
suggests that E2F-DB occupies the E2F sites in E2F-responsiveHelin, 2000). The pocket proteins not only interfere with trans-
promoters in vivo. To address this, we performed chromatinactivation, but form, upon association with E2F and histone
immune precipitation (ChIP) on E2F-DB, followed by real-timedeacytelases (HDACs), active transcriptional repressor com-
PCR on three different E2F-responsive promoters. Consistentplexes (Harbour and Dean, 2000; Zhang et al., 2000). E2F-6 is
with the results obtained by EMSA, we observed that in E2F-unique in that it has a pocket protein-independent repression
DB-expressing MEFs, significant amounts of E2F-DB occupymotif (Cartwright et al., 1998; Gaubatz et al., 1998; Trimarchi
the p19ARF, CYCLIN A, and CYCLIN E promoters (Figure 1C).et al., 1998). The pRB family controls cell cycle progression by
Together, these data provide strong evidence that E2F-DB actstransiently associating with E2Fs. During G1, D type CYCLINS
to displace endogenous E2Fs from E2F-responsive promoters.activate CDK4 and CDK6, which in turn phosphorylate pRB
(Weinberg, 1995). pRB and HDAC subsequently dissociate,
Endogenous E2Fs act as repressors in cyclingwhich results in derepression of E2F target genes (Zhang et
primary murine fibroblastsal., 2000). Further phosphorylation of pRB by CYCLIN E-CDK2
The E2F transcription factors have the ability to mediate eithercauses pRB to dissociate from E2F, thereby actively inducing
transcriptional repression or activation. In order to determineE2F-dependent transactivation and stimulating the cell to enter
the relative contribution of these two functions on the regulationS phase (Harbour et al., 1999).
of endogenous target genes of E2F, we compared wild-type
Pocket proteins are not the only communicative link be-
E2F-1 to mutants of E2F-1, which lack either the repression
tween senescence signaling and the E2F transcription factors.
function only (E2F-1 (Y411C)) or both the repression and trans-
A number of additional observations suggest a possible role for activation functions (E2F-DB). Upon retroviral expression in pri-
E2F in the regulation of senescence: the levels of various E2Fs mary MEFs, wild-type E2F-1 differentially induced its transcrip-
decrease during the onset of senescence (Dimri et al., 1994; tional targets p19ARF, PCNA, p107, MCM3, and CYCLINS E1
Haddad et al., 1999), and overexpressed E2F-1 induces both and A (Figure 2A). E2F-DB, on the other hand, markedly induced
ARF (Bates et al., 1998; DeGregori et al., 1997; Dimri et al., all of these targets (Figure 2A). This was not a global effect of
2000) and premature senescence (Dimri et al., 2000). To analyze E2F-DB, as the expression of p16INK4a, CYCLIN D1, and CDK4
in more detail its role in senescence, we disrupted the transcrip- remained unaffected (Figure 2E). As expected, a DNA binding-
tion-regulating function of E2F and analyzed the (p19ARF/p53- deficient mutant of E2F-DB (E2F-DB (E132)) (Hsieh et al., 1997)
dependent) senescence response in primary murine fibroblasts. failed to induce the expression of the E2F target genes
As E2Fs have the ability to mediate active transcriptional repres- (Figure 2B).
sion, as well as activation, we also addressed in primary MEFs If endogenous E2Fs act predominantly to activate transcrip-
which of these functions is required for the transcriptional regu- tional targets, one would expect that E2F-DB would interfere
lation of endogenous E2F target genes, including p19ARF, and with this activation, something we clearly did not observe. We
for an adequate response to antiproliferative p19ARF/p53 sig- therefore conclude that in cycling primary MEFs, endogenous
naling. E2F controls target gene expression predominantly by means
of active repression. Restoration of specifically E2F’s transacti-
Results vation function (i.e., expression of E2F-1 (Y411C)), which trans-
activates but does not repress (Helin et al., 1993), failed to give
Ectopic expression of an E2F-1 C-terminal deletion rise to additional induction on top of that achieved by E2F-DB,
mutant displaces endogenous E2Fs from DNA indicating that the transactivating function of E2F-1 is dispens-
Overexpression of E2F-1 has been reported to induce ARF able for the induction of at least this set of E2F target genes.
transcription (Bates et al., 1998; DeGregori et al., 1997; Dimri As E2F-1 controls its own transcription (Hsiao et al., 1994; John-
et al., 2000). To address whether p19ARF is also subjected to son et al., 1994; Neuman et al., 1994), we wished to exclude
transcriptional repression by endogenous E2Fs, we interfered that E2F-DB induces the levels of transcriptionally competent
with E2F signaling by the use of a mutant of E2F-1 (E2F-DB; endogenous E2F-1, which in turn switches on expression of E2F
Figure 1A) in primary MEFs. E2F-DB lacks both the C-terminal target genes. Indeed, the levels of endogenous E2F-1 remained
transactivation and the pRB binding domains, but can still bind unaltered in the presence of E2F-DB (Figure 2E), excluding this
to DNA in heterodimeric complex with DP-1. E2F-DB has been possibility.
used previously to rescue pocket protein-mediated transcrip- E2F-mediated transcriptional repression occurs through as-
tional repression (Johnson, 1995; Qin et al., 1995) and to show sociation with pocket proteins. Hence, it seemed likely that the
E2F-DB-mediated derepression is pocket protein dependent.that cell cycle arrest induced by either p16INK4a, TGF, or contact
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Figure 1. Ectopic expression of an E2F-1 C-terminal deletion mutant displaces endogenous E2Fs from DNA
A: Schematic representation of the E2F-1 mutants used in this study. B: E2F-DB displaces endogenous E2F from the DNA. Nuclear extracts were prepared
from primary p53/ MEFs infected with retroviruses encoding E2F-DB or control viruses and analyzed by EMSA for E2F DNA binding activity in the absence
or presence of antibodies for E2F-DB or E2F-4. C: E2F-DB binds to E2F-responsive promoters in vivo. ChIP assays performed in wild-type primary MEFs for E2F-
DB on the p19ARF, CYCLIN A, and CYCLIN E promoters. Data are represented as real-time PCR signals from p19ARF, CYCLIN A, or CYCLIN E, relative to a
-ACTIN control PCR performed on the same ChIP.
To address this directly, we infected MEFs deficient for all three RASV12 and required for RASV12-induced senescence (Palmero et
al., 1998), raising the possibility that p19ARF induction by RASV12pocket proteins (TKO MEFs) (Dannenberg et al., 2000) with E2F-
DB-encoding retrovirus. Whereas E2F-DB derepressed p19ARF, requires E2F activity. However, E2F-DB did not inhibit p19ARF
induction by RASV12, but rather enforced it (Figure 2E). ThePCNA, CDK1, MCM3, and CYCLINS E1 and A in wild-type
MEFs, this regulation was completely absent in TKO MEFs (al- RASV12-dependent induction of p19ARF in the presence of E2F-
DB was functional, as it led to an increase in p53 levels (Figurethough E2F-DB was expressed slightly less in TKO MEFs than
in wild-type MEFs; Figure 2C). These results demonstrate that 2E). This result strongly suggests that RASV12-dependent induc-
tion of p19ARF and p53 does not require E2F-mediated transacti-in MEFs, the observed E2F-dependent repression of target
genes is mediated mainly, if not exclusively, by pocket proteins. vation.
Importantly, in TKO MEFs, we also failed to observe an E2F-
DB-mediated decrease in the levels of E2F targets, which, as Disruption of E2F-dependent repression results
in immortalizationE2Fs in these cells are thought to be free and transactivation
competent, supports our notion that in proliferating MEFs, E2Fs Increased p19ARF levels cause cell cycle arrest or senescence
(Kamijo et al., 1997; Quelle et al., 1995). As E2F-DB derepressedserve mainly as repressors of transcription.
Recently, p19ARF was shown to bind to E2F-1 and target it for p19ARF expression in MEFs, we expected that E2F-DB would
cause premature senescence. Surprisingly, whereas control-degradation (Martelli et al., 2001). Possibly, E2F-DB sequesters
p19ARF and thereby protects endogenous E2F from degradation, infected MEFs lost their replicative potential, at least initially (see
below), cells expressing E2F-DB completely failed to undergoleading to the induction of E2F target genes. However, E2F-
DB-dependent derepression of all E2F targets tested occurred senescence (Figure 3A). This effect of E2F-DB was independent
of its CYCLIN A binding domain (Figure 3B), which is requiredsimilarly (albeit to different extents) in wild-type and p19ARF/
MEFs, excluding an important role for p19ARF in this respect to appropriately inactivate the DNA binding function of E2F in
S phase (Krek et al., 1994). Moreover, this bypass of senescence(Figure 2D).
Expression of p19ARF, an E2F target gene, is induced by was not observed for wild-type E2F-1, which caused both cell
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Figure 2. Endogenous E2Fs act as repressors in primary murine fibroblasts
A: Disruption of E2F function results in derepression of various E2F targets. Young primary wild-type MEFs were infected with retroviruses encoding E2F-DB,
E2F-1, or E2F-1 (Y411C). At 5 days after infection, cell extracts were prepared and subjected to Western blotting with the indicated antibodies. B: E2F-DB-
mediated derepression requires its DNA binding function. MEFs were infected with E2F-DB, E2F-DB (E132), or control viruses and processed as in A. C: E2F-
dependent repression is mediated by pocket proteins. Wild-type and Rb//p107//p130/ (TKO) MEFs were infected with E2F-DB or control viruses and
processed as in A. D: E2F-dependent repression is independent of p19ARF status. Wild-type and p19ARF/ MEFs were infected and processed as in A. E:
RASV12 induces p19ARF independent of E2F transactivation. Wild-type MEFs were infected with retroviruses encoding E2F-DB, RASV12, or both. Cell extracts
were prepared at 6 days after infection. Similar observations were made for extracts prepared at 3, 12, and 24 days postinfection (not shown). In all panels,
CDK4 served as a loading control.
death and premature senescence (consistent with previous re- 20 continued to abundantly express both p19ARF and p16INK4a
(Figure 3E). By contrast, spontaneously immortalized (“3T3”)ports; DeGregori et al., 1997; Dimri et al., 2000; Qin et al., 1994;
Shan et al., 1994; Wu and Levine, 1994; Figures 3A and 3D), mouse fibroblasts had lost expression of p19ARF. We then used
the DNA damage-induced stabilization of p53 and concomitantnor was it observed for E2F-1 (24) lacking the CYCLIN A
binding domain (Figure 3B). The pRB binding-deficient E2F-1 transcriptional activation of p21CIP1 to determine whether p53
was still functional in the E2F-DB-immortalized MEFs. cis-platin(Y411C) mutant caused cell death (Figure 3B), although espe-
treatment led to stabilization of p53 in all four late-passage E2F-cially at higher cell density, a substantial amount of the cells
DB-expressing lines (Figure 3F). Moreover, p53 was functional,did continue to proliferate (Figure 3D). As expected, the DNA
as DNA damage increased the levels of its transcriptional targetbinding-deficient point mutant of E2F-DB failed to yield any
p21CIP1 (Figure 3F).proliferative advantage (Figure 3C).
We next determined whether the E2F-DB-mediated immor-
talization requires mutations in the genes that are frequently Disruption of E2F-dependent repression results
in bypass of RASV12-induced senescencemutated during spontaneous immortalization, namely p19ARF
and p53. We propagated four independent E2F-DB-expressing RASV12-induced premature senescence much resembles spon-
taneous senescence of primary cells. Therefore, we testedMEF populations for 20 passages and then analyzed p16INK4a,
p19ARF, p53, and p21CIP1 levels, as well as p53 function. Com- whether disruption of E2F transcriptional repression not only
leads to immortalization of primary MEFs, but also rescuespared to control MEFs at passage 8, E2F-DB MEFs at passage
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Figure 3. Disruption of E2F-dependent repression results in immortalization
A: E2F-DB immortalizes primary MEFs. Wild-type, primary MEFs at passage 3 were infected with pBABE-puro retroviruses encoding wild-type or mutant E2F-1,
as indicated. At 2 days postinfection, infected cells were selected for expression of the puromycin-selectable marker for 5 days and used in a proliferation
curve performed in duplicate. B: Immortalization by E2F-DB does not require a CYCLIN A binding domain. MEFs were infected with retroviruses encoding
E2F-1 (24), E2F-DB (24), or E2F-1 (Y411C). Analysis was performed as in A. C: Immortalization by E2F-DB requires its DNA binding function. MEFs were
infected with retroviruses encoding E2F-DB, E2F-DB (E132), or control viruses. Analysis was performed as in A. D: E2F-1 (Y411C) can stimulate MEF proliferation.
Low-passage MEFs were infected with either E2F-DB, E2F-1 (wild-type), or E2F-1 (Y411C) and cultured under subconfluent conditions. Photographs were
taken at passage 7. E: Immortalization by E2F-DB occurs in the presence of p19ARF and p16INK4a. Western blot analysis for the indicated proteins of immortal
E2F-DB-expressing MEF clones at passage 20. 3T3 indicates a spontaneously immortalized MEF clone (Vector I from the growth curve in A) that apparently
had lost p19ARF expression. E2F-DB lines 3 and 4 represent cell extracts taken from E2F-DB lines I and II, respectively, also taken from the growth curve in A.
E2F-DB lines 1 and 2 are independently propagated MEFs. MEF indicates passage 8 primary MEFs. CDK4 served as a loading control. F: Immortalization by
E2F-DB occurs in the presence of functional p53. Western blot analysis of the indicated proteins of immortal E2F-DB-expressing MEF clones at passage 20,
after 16 hr treatment with cis-platin (50 M). CDK4 served as a loading control.
RASV12-induced premature senescence. MEFs expressing only 4B). Thus, disruption of E2F function results in derepression of
p19ARF, but in spite of this, it also concomitantly causes aRASV12 prematurely senesced, although after prolonged cultur-
bypass of both spontaneous and RASV12-induced senescence,ing one of these populations (“RASV12 II”) regained proliferative
thereby allowing cells to proliferate indefinitely while ignoringpotential (Figure 4A; see below). By contrast, MEFs expressing
the sharp elevation in endogenous p19ARF levels.both RASV12 and E2F-DB, in spite of overexpressing RASV12
(not shown), efficiently bypassed RASV12-induced senescence
(Figure 4A). Disruption of E2F-dependent repression rescues cell
cycle arrest induced by ectopically expressedLike E2F-DB-immortalized MEFs, both RASV12/E2F-DB MEF
lines had retained normal expression of both p19ARF and p53, p19ARF and p53
The results shown above strongly argue that endogenous E2Fas well as of p16INK4a (Figure 4B). This was in contrast to a
spontaneously immortalized RASV12-expressing cell line (RASV12 repressor function is required for cells to respond to senes-
cence-associated induction of p19ARF. To test whether E2F-DBII) that had lost expression of both p16INK4a and p19ARF (Figure
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Figure 4. Disruption of E2F-dependent repression
results in bypass of RASV12-induced senescence
A: E2F-DB expression allows primary MEFs to by-
pass RASV12-induced senescence. Wild-type, pri-
mary MEFs at passage 3 were (co-) infected with
retroviruses encoding RASV12 and either control
or E2F-DB-encoding retroviruses, selected for pu-
romycin and hygromycin, and processed as de-
scribed for Figure 3A. B: Bypass of RASV12-induced
senescence by E2F-DB occurs in the presence
of p19ARF, p16INK4a, and p53. Western blot analysis
of passage 15 clones, after completion of the
growth curves described in A. p53m/3T3 (lane 4)
indicates a spontaneously immortalized MEF
clone expressing high levels of mutant p53,
which failed to transcriptionally activate p21CIP1.
CDK4 served as a loading control.
can bypass also an ectopic p19ARF-induced cell cycle arrest, we contrast, this arrest was reduced by half in E2F-DB-expressing
cells. This observation was supported by a colony formationgenerated NIH 3T3 cell lines stably expressing E2F-DB or empty
vector. These cell lines retained functional p53, as judged by assay: upon infection with a retrovirus producing a p19ARF-RFP
chimeric protein, the control population showed only few prolif-its DNA damage-induced stabilization and concomitant induc-
tion of p21CIP1 (data not shown). We infected both cell popula- erating, p19ARF-positive cells (Figure 5B). In fact, the small num-
ber of cells that did express p19ARF (localized in the nucleoli, intions with a p19ARF-encoding retrovirus. As expected, p19ARF
induced a robust G1 arrest in the control cells (Figure 5A). By agreement with previous observations; Weber et al., 1999;
Figure 5. Disruption of E2F-dependent repression rescues cell cycle arrest induced by ectopically expressed p19ARF and p53
A: E2F-DB interferes with cell cycle arrest induced by overexpression of p19ARF. Parental or E2F-DB-expressing NIH-3T3 cells were infected with either control
or p19ARF-ires-GFP-encoding retroviruses (either undiluted or diluted into medium, as indicated) and treated with nocodazole (50 ng/ml) to specifically
analyze the cell fraction in G1. At least 90% of the cells were infected, as judged by the number of GFP-positive cells. At 48 hr after infection, the cell cycle
profile was determined by FACS analysis. B: E2F-DB interferes with inhibition of colony formation by overexpression of p19ARF. Parental or E2F-DB-expressing
NIH-3T3 cells were infected with either control or LZRS-p19ARF-RFP-ires-zeo retrovirus. At 6 days after infection, fluorescence microscopy photographs were
taken. Representative examples are shown. C: E2F-DB interferes with cell cycle arrest induced by overexpression of p53. Parental or E2F-DB-expressing
p53/ cells were infected with either control or LZRS-p53-RFP-ires-zeo retrovirus (either undiluted or diluted into medium, as indicated). BrdU incorporation
was measured 48 hr after infection. D: E2F-DB interferes with inhibition of colony formation by overexpression of p53. Parental or E2F-DB-expressing p53/
cells were infected as in C. At 6 days after infection, fluorescence microscopy photographs were taken. Representative examples are shown.
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Zhang and Xiong, 1999) had a large and flattened morphology,
typical of senescent cells. Apparently, strong selection occurred
against maintaining p19ARF expression. By contrast, the vast
majority of the E2F-DB-expressing cells produced clearly de-
tectable levels of p19ARF without displaying a senescent mor-
phology (Figure 5B), reinforcing our notion that ectopically ex-
pressed p19ARF blocks cellular proliferation in an E2F-dependent
manner.
E2F-DB rescued p19ARF-induced cell cycle arrest, a p53-
dependent event (at least in part), raising the possibility that
E2F-DB acts downstream of p53. To test this, we established
p53/ MEFs stably expressing E2F-DB, which we subsequently
infected with a p53-encoding retrovirus. As expected, control
cells ceased to undergo DNA replication almost completely
upon expression of p53 (Figure 5C). By contrast, in the presence
of E2F-DB, p53 decreased the number of cells undergoing DNA Figure 6. E2F activity is required for cell cycle reentry from quiescence
replication only by roughly half. In support of this finding, we NIH 3T3 cell lines stably expressing either E2F-DB or empty vector were propa-
gated in 10% serum and subsequently deprived of serum for 72 hr. Then,observed that in a colony formation assay, E2F-DB-expressing
the cells were refed with 10% serum for 24 hr. Represented is the proportionMEFs continued to proliferate despite clearly detectable levels
of cells incorporating BrdU, as a measure of DNA synthesis, in each situation.of retrovirally expressed p53-RFP fusion protein, which was
Average and standard deviations are based on three independent experi-
localized in the nucleus (Figure 5D). In control cells, neither ments.
abundant expression nor nuclear localization of p53-RFP was
compatible with proliferation, and cells that did express p53-
RFP again displayed a “flat-cell” phenotype (Figure 5D). Thus,
E2F-DB not only rescues spontaneous senescence (a p19ARF- Discussion
and p53-dependent process), but also significantly interferes
with a cell cycle arrest imposed by ectopic overexpression of E2F-mediated transcriptional repression
p19ARF and p53. These results further support our notion that and p19ARF-dependent regulation of senescence
E2F acts downstream of both p19ARF- and p53-dependent anti- We demonstrate that in primary murine fibroblasts, various E2F
proliferative signaling. targets, including p19ARF, are repressed rather than transacti-
vated by endogenous E2F. More importantly, disruption of E2F-
E2F activity is required for cell cycle reentry mediated repression allowed MEFs to bypass both spontaneous
from quiescence and RASV12-induced senescence and to proliferate indefinitely,
The data above show that E2F’s transactivation function is dis- in the face of high levels of p19ARF. We therefore conclude that
pensable for the induction of (at least a number of) E2F target p19ARF promotes proliferative arrest in an E2F transcriptional
genes. Moreover, they strongly suggest that the absence of repression-dependent manner, a notion that is reinforced by
E2F-mediated transactivation is compatible with proliferation of our observation that disruption of E2F repression interfered also
primary murine cells, something that has been reported pre- with the induction of cell cycle arrest by ectopically expressed
viously for other cell types (Sellers et al., 1995; Zhang et al., 1999; p19ARF or p53.
He et al., 2000). However, most E2Fs possess a transactivation Expression of E2F-DB led to induction (i.e., derepression),
domain, arguing that specific situations should exist where as opposed to reduction (i.e., loss of transactivation), of various
transactivation is required. Indeed, ectopic E2F-1-mediated E2F targets, including p19ARF. Moreover, similar to E2F-DB-
transactivation, but not repression, is sufficient to induce S expressing MEFs, pRB family-deficient MEFs, which lack E2F-
phase entry in the absence of mitogens (Johnson et al., 1993; repressor complexes, are immortal despite high levels of p19ARF.
Kowalik et al., 1995; Qin et al., 1994; Shan et al., 1996). More- These observations indicate that in primary MEFs, it is specifi-
over, E2F1/ fibroblasts display a delayed G0-S transition in cally E2F’s transcriptional repression function, but not its trans-
response to mitogen stimulation (Wang et al., 1998). We there- activation function, which is required for the senescence check-
fore investigated whether endogenous E2F transactivation func- point. What, then, is the function of E2F’s transactivation
tion is not only sufficient, but also required for mitogen-induced domain? We observed neither an effect of E2F-DB on the levels
cell cycle reentry. of p19ARF (or other E2F targets) in pRB family-deficient cells, nor
We deprived E2F-DB expressing cells of serum, which a contribution of E2F’s transactivation domain on top of the
caused them to exit the cell cycle as efficiently as control cells induction of E2F target genes by E2F-DB in wild-type MEFs.
(Figure 6). Apparently, in immortal murine fibroblasts, no E2F Although we cannot exclude that in proliferating cells some
function is required for G0 entry, consistent with previous obser- residual E2F transactivator function remains despite the pres-
vations in other cell types (Zhang et al., 1999). By contrast, ence of E2F-DB, our results argue that in cycling primary MEFs,
upon serum refeeding, the control cells readily reentered the cell E2F-dependent transactivation is dispensable. By contrast,
cycle, whereas the E2F-DB-expressing cells were significantly E2F-DB did efficiently prevent mitogen-stimulated cell cycle
impaired in their DNA replication (Figure 6). Taken together, reentry. Our data therefore suggest that E2F-dependent trans-
this suggests that loss of E2F transcriptional activity prevents activation is required only in specific circumstances, like in the
mitogen-induced cell cycle reentry, indicating that in this spe- presence of apoptosis-inducing signals or during cell cycle reen-
try (as shown schematically in Figure 7). Furthermore, we showcific situation, E2F-mediated transactivation is required.
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Figure 7. Hypothetical model for E2F function in cell cycle regulation
See text for details.
that it is specifically E2F-dependent repression that is required Primary MEFs expressing E2F-DB produce elevated levels
of CYCLIN E1, which can contribute to immortalization (Peeperfor cell cycle exit in response to activation of the p19ARF/p53
pathway. et al., 2002). In fact, overexpression of CYCLIN E1 has been
observed in, and most likely contributes to the emergence of,Although various E2F target genes were derepressed both in
E2F-DB-expressing wild-type MEFs and in pRB family-deficient many human tumors (Keyomarsi and Herliczek, 1997). However,
it clearly is not the sole target in this respect, as also Rb-deficientMEFs, the extent of derepression was greater (with the excep-
tion of CYCLIN E) in the latter cell type. This can be explained MEFs produce high levels of CYCLIN E1 (Herrera et al., 1996),
yet undergo senescence normally. Indeed, numerous genes areby the fact that E2F-DB acts in a dominant-negative manner
and displaces most, but not all, endogenous E2F complexes regulated by the pRB/E2F pathway, strongly suggesting that
immortalization requires derepression of a number of E2F tar-from the DNA (see Figure 1B). By contrast, pRB family-deficient
MEFs completely lack E2F/pocket protein complexes and as a gets. An important question that remains to be addressed is how
p19ARF/p53 signaling leads to a requirement for E2F repressorresult show maximal derepression of E2F targets. Importantly,
ectopic expression of E2F-DB and genetic ablation of pocket complexes in a pathway leading to proliferative arrest. In this
respect, we note that our data do not discriminate between aproteins do result in a similar biological phenotype: both interfere
with the senescence checkpoint and lead to immortalization. linear pathway between p19ARF/p53 and E2F and a more indirect
mechanism of communication with intermediary signals.Recent data show that the simultaneous absence of E2Fs
1, 2, and 3 causes defects in G1/S target gene activation and
inhibition of proliferation (Wu et al., 2001). This may seem at Communication between p19ARF, p16INK4a, p53, and E2F
It has been suggested previously that p19ARF requires functionalodds with our finding that MEFs proliferate well in the presence
of E2F-DB. However, whereas in E2F-1-3 triple knockout cells p16INK4a to induce cell cycle arrest (Carnero et al., 2000). As E2F-
DB rescues not only p19ARF-induced arrest, as we show here,E2F-4 and E2F-5 are free to repress transcription and thereby
may inhibit proliferation, this is compromised by E2F-DB, as but also a p16INK4a-induced arrest (Zhang et al., 1999), and since
E2F-DB-expressing MEFs proliferate in the presence of normalthis displaces endogenous E2Fs from E2F sites (Krek et al.,
1995; Zhang et al., 1999). p16INK4a levels, it is formally possible that E2F-DB immortalizes
by acting downstream of p16INK4a. Recent data, however, revealPrevious studies (Bates et al., 1998; Dimri et al., 2000)
showed that wild-type E2F-1 induced the human p14ARF gene, that p16INK4a is dispensable both for spontaneous and RASV12-
induced senescence in MEFs (Krimpenfort et al., 2001;whereas E2F-DB did not. This seemingly is in contrast with our
present observations with E2F-DB. However, Bates et al. made Sharpless et al., 2001). This makes it highly unlikely that disrup-
tion of E2F-dependent repression renders MEFs immortaltheir observations in SAOS-2 cells, which lack functional pRB
and therefore contain only a limited amount of E2F repressor through interference with p16INK4a signaling and argues in favor of
our model that in senescence signaling, the p19ARF/p53 pathwaycomplexes. On the other hand, Dimri et al. used primary human
WI-38 fibroblasts, which suggests that E2F-dependent ARF reg- acts in an E2F-dependent manner.
In conclusion, we show that in primary MEFs, E2F-mediatedulation varies depending on species or cell type, possibly as a
result of differences in the composition and/or quantity of E2F repression is linked to antiproliferative signaling by p19ARF in at
least two ways (Figure 7). Upstream, E2F represses p19ARF,complexes. For some targets we did observe induction by wild-
type E2F-1, consistent with previous reports (Muller and Helin, in a pocket protein-dependent manner. Downstream, functional
E2F is required for both p19ARF and p53 to induce cell cycle arrest2000). However, we propose that some effects of overexpressed
wild-type E2F may be caused by titrating cellular factors like and for the appropriate execution of the senescence program.
Interestingly, the INK4a locus encodes two unrelated proteins,pocket proteins away from E2F sites in promoters. In this case,
the net effect would be similar to what we describe here for the p16INK4a and p19ARF, proposed to act in independent pathways,
namely pRB- and p53-dependent, respectively. The Dean andtranscription-deficient E2F-DB mutant, namely an increase in
the levels of E2F targets, like ARF. Livingston laboratories have previously demonstrated that E2F
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with protein A/G-Sepharose beads. Immunoprecipitates were washed se-repressor complexes are required for an appropriate cellular
quentially with 0.1% SDS, 1% Triton X-100, 0.1% deoxycholate, 0.15 Mresponse to p16INK4a (Gaubatz et al., 2000; Zhang et al., 1999).
NaCl, 1 mM EDTA, 10 mM Tris (pH 8.0), 0.5 mM EGTA; 0.1% SDS, 1%Quite unexpectedly, however, we find that E2F repressor com-
Triton X-100, 0.1% deoxycholate, 0.5 M NaCl, 1 mM EDTA, 10 mM Tris (pH
plexes are also essential for cell cycle exit in response to the 8.0), 0.5 mM EGTA; 0.25 M LiCl, 0.5% deoxycholate, 0.5% NP-40, 1 mM
other INK4a product, p19ARF. Thus, together these findings sug- EDTA, 10 mM Tris (pH 8.0), 0.5 mM EGTA, and 1 mM EDTA, 10 mM Tris
gest that p16INK4a and p19ARF/p53 do not operate independently, (pH 8.0), 0.5 mM EGTA. Immunocomplexes were eluted twice from the
beads in 1% SDS, 0.1 M NaHCO3 at room temperature for 15 min. Protein-but converge on E2F repressor complexes. This model would
DNA crosslinks were reversed in 0.2 M NaCl at 65C for 4 hr, after whichpredict that tumors with mutations in the INK4a locus (as well
DNA was isolated by phenol-chloroform extraction. Real-time PCR wasas in p53) share deregulation of E2F-controlled target genes,
performed using the GeneAmp 5700 Sequence Detection System (PE Bio-irrespective of which INK4a gene is affected. As the E2F repres-
systems) using the SYBR Green I kit (PE Biosystems). Primers used for real-
sor complex is controlled by these two major tumor suppressor time PCR were for p19ARF (E2F binding sites region), (forward) TTTTTATA
pathways, our model predicts that E2F-dependent transcrip- GATGGACTCGGAGCAA and (reverse) GTCCCGAAACTTTCGTCTATGC; for
tional repression is deregulated in the vast majority of human CYCLIN A (E2F binding sites region), (forward) CCGGCGCTTCTGGTGAC
and (reverse) CAAGTAGCCCGCGACTATTGA; for CYCLIN E (E2F bindingtumors.
sites region), (forward) GGGCGTGTTCTTTTACGGG and (reverse) GCC
CTGACATCTAGCCCCA; and for -ACTIN (exon 5), (forward) TCCGCAAAGAExperimental procedures
CCTGTATGCC and (reverse) CTCCTTCTGCATCCTGTCAGC.
Cell culture
Cell cycle analysis and fluorescence microscopyMEFs of OLA and FVB origin were isolated as described (Peeper et al., 2001)
NIH-3T3 cells were infected with pBABE-puro-HA-E2F-DB or parentaland cultured in DMEM medium supplemented with 10% FBS, L-Glutamine,
pBABE-puro retroviruses, and polyclonal pools were selected for puromycinand penicillin/streptomycin (all GIBCO) and 0.1 mM -mercaptoethanol. NIH-
resistance. For FACS analysis, cells were infected with MSCV-p19ARF-ires-3T3 cells were cultured as MEFs, but with 10% NCS (GIBCO) and without
GFP or MSCV control virus. After 32 hr, 50 ng/ml nocodazole was added-mercaptoethanol. The Phoenix packaging cell line was used for the gener-
to the medium for 16 hr. Then, cells were permeabilized and stained withation of ecotropic retroviruses (Serrano et al., 1997). MEFs were infected
propidium iodide, and cell cycle profiles were determined by FACS analysisfor 8 hr with filtered (0.45 m) virus supernatant supplemented with 8 g/ml
and analyzed using CellQuest software. For fluorescence microscopy, cellspolybrene.
were infected with LZRS-p19ARF-RFP-ires-zeo or parental pLZRS-ires-zeoProliferation curves were performed by infection of low-passage MEFs
retroviruses. Cells were plated at 105 cells/10 cm dish. Photographs werewith pBABE-puro retroviral vectors containing HA-E2F-1 (wild-type or mu-
taken after 6 days of zeocin selection using fluorescence microscopy, attant, as described in Figure 1) and pBABE-hygro retroviral vectors containing
60 magnification.RASV12. Cells were subsequently selected for puromycin and hygromycin
p53/ MEFs were infected with pBABE-puro-HA-E2F-DB or parentalresistance until all uninfected cells had died. Then, 1.5  105 cells were
pBABE-puro retroviruses, and polyclonal pools were selected for puromycinseeded in a 6 cm dish and counted and split every 3.5 days. For cis-platin
resistance. Subsequently, cells were infected with pLZRS-p53-RFP-ires-zeotreatment, E2F-DB immortalized MEFs were cultured for 20 passages and
or parental pLZRS-ires-zeo retroviruses. At 48 hr postinfection, 7.5 g/mlincubated in 50 M cis-platin for 16 hr.
bromo-deoxyuridine (BrdU) was added to the medium for 1 hr. Then, cells
were processed for staining with anti-BrdU antibodies. FACS analysis andPlasmids
fluorescence microscopy were performed as described above. For serumpBABE-puro vectors containing HA-tagged E2F-1 wild-type, E2F-1 (1–368),
starvation experiments, NIH-3T3 cells expressing E2F-DB or control cellsE2F-1 (24), and E2F-1 (1–368 24) were kind gifts from W. Krek (Krek et
were propagated in medium containing 10% NCS. Hereafter, cells wereal., 1995). E2F-1 mutants (1–374) (Helin and Harlow, 1994), E2F-1 (1–374,
starved in 0.1% serum for 72 hr and then refed with 10% serum for 24 hrE132) (Hsieh et al., 1997), and E2F-1 (Y411C) (Helin et al., 1993) were sub-
in the presence of 7.5 g/ml BrdU.cloned into pBABE-puro. LZRS-p19ARF-RFP-ires-zeo and LZRS-p53-RFP-
ires-zeo retroviral vectors were kindly provided by T. Brummelkamp. MSCV-
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